Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Reinvestment Rate
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Reinvestment Rate of 0.99x as of December 2025, reinvesting €10.80 Billion (capex €7.32 Billion plus investments €-3.48 Billion) from operating cash flow of €10.91 Billion. Explore RDDA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dr. Reddy's Laboratories Limited Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Dr. Reddy's Laboratories Limited across 9 annual periods. Also explore Dr. Reddy's Laboratories Limited balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year capital reinvestment analysis for Dr. Reddy's Laboratories Limited. For live market cap and broader valuation context, see Dr. Reddy's Laboratories Limited (RDDA) total market value.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.28x | €59.52 Billion | €46.43 Billion | €34.40 Billion | ▼ -14.0% |
| 2024 | 1.49x | €67.72 Billion | €45.43 Billion | €27.43 Billion | ▲ +45.7% |
| 2023 | 1.02x | €60.24 Billion | €58.88 Billion | €18.87 Billion | ▲ +11.2% |
| 2022 | 0.92x | €25.86 Billion | €28.11 Billion | €14.66 Billion | ▲ +137.2% |
| 2021 | 0.39x | €13.85 Billion | €35.70 Billion | €9.74 Billion | ▲ +128.8% |
| 2020 | 0.17x | €5.06 Billion | €29.84 Billion | €4.85 Billion | ▼ -47.3% |
| 2019 | 0.32x | €9.24 Billion | €28.70 Billion | €6.96 Billion | ▼ -57.6% |
| 2018 | 0.76x | €13.68 Billion | €18.03 Billion | €9.29 Billion | ▼ -52.2% |
| 2017 | 1.59x | €34.14 Billion | €21.51 Billion | €12.28 Billion | — |